Liver fibrosis
Top Cited Papers
Open Access
- 1 February 2005
- journal article
- Published by American Society for Clinical Investigation in Journal of Clinical Investigation
- Vol. 115 (2) , 209-218
- https://doi.org/10.1172/jci200524282
Abstract
Liver fibrosis is the excessive accumulation of extracellular matrix proteins including collagen that occurs in most types of chronic liver diseases. Advanced liver fibrosis results in cirrhosis, liver failure, and portal hypertension and often requires liver transplantation. Our knowledge of the cellular and molecular mechanisms of liver fibrosis has greatly advanced. Activated hepatic stellate cells, portal fibroblasts, and myofibroblasts of bone marrow origin have been identified as major collagen-producing cells in the injured liver. These cells are activated by fibrogenic cytokines such as TGF-β1, angiotensin II, and leptin. Reversibility of advanced liver fibrosis in patients has been recently documented, which has stimulated researchers to develop antifibrotic drugs. Emerging antifibrotic therapies are aimed at inhibiting the accumulation of fibrogenic cells and/or preventing the deposition of extracellular matrix proteins. Although many therapeutic interventions are effective in experimental models of liver fibrosis, their efficacy and safety in humans is unknown. This review summarizes recent progress in the study of the pathogenesis and diagnosis of liver fibrosis and discusses current antifibrotic strategies.Keywords
This publication has 117 references indexed in Scilit:
- A dual reporter gene transgenic mouse demonstrates heterogeneity in hepatic fibrogenic cell populationsHepatology, 2004
- Antisense strategy against PDGF B-chain proves effective in preventing experimental liver fibrogenesisBiochemical and Biophysical Research Communications, 2004
- Hepatic fibrogenesis requires sympathetic neurotransmittersGut, 2004
- Toll–Like Receptor 4 Mediates Inflammatory Signaling by Bacterial Lipopolysaccharide in Human Hepatic Stellate CellsHepatology, 2003
- Liver fibrosis – from bench to bedsideJournal of Hepatology, 2003
- Relaxin inhibits effective collagen deposition by cultured hepatic stellate cells and decreases rat liver fibrosis in vivoGut, 2001
- Interactions between Hepatic Stellate Cells and the Immune SystemSeminars in Liver Disease, 2001
- Apolipoprotein E polymorphism, a marker of disease severity in primary biliary cirrhosis?Journal of Hepatology, 2001
- Acetalde hyde‐Induced Stimulation of Collagen Synthesis and Gene Expression Is Dependent on Conditions of Cell Culture: Studies with Rat Lipocytes and FibroblastsAlcohol, Clinical and Experimental Research, 1994
- Histological course of alcoholic hepatitisJournal of Hepatology, 1986